A Open-label, Radomized, Crossover Clinical Trial to Assess the Pharmacokinetics of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Yuhan
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 27 Jun 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Jun 2016 New trial record